OCT1 and OCT2 are involved in renal secretion of cationic drugs. Although they have similar selectivity for some substrates (e.g. tetraethylammonium (TEA)), they have distinct selectivities for others (e.g. cimetidine). We postulated that "homolog-specific residues," i.e. the 24 residues that are conserved in OCT1 orthologs as one amino acid and in OCT2 as a different one, influence homologspecific selectivity and examined the influence on substrate binding of three of these conserved residues that are found in the C-terminal half of the rabbit orthologs of OCT1/2. The N353L and R403I substitutions (OCT2 to OCT1) did not significantly change the properties of OCT2. However, the E447Q replacement shifted substrate selectivity toward an OCT1-like phenotype. Substitution of glutamate with cationic amino acids (E447K and E447R) abolished transport activity, and the E447L mutant displayed markedly reduced transport of TEA and cimetidine while retaining transport of 1-methyl-4-phenylpyridinium. In a novel homology model of the three-dimensional structure of OCT2, Glu 447 was found in a putative docking region within a hydrophilic cleft of the protein. Renal excretion is the principal pathway for elimination of many clinically used drugs and is the exclusive pathway for eliminating many end products of drug-metabolizing enzymes (1-3). Transporters in the renal tubule epithelium mediate secretion and thus play a critical role in detoxification (4). In addition, transporters control the exposure of renal cells to nephrotoxic drugs and environmental toxins and thereby influence xenobiotic-induced nephrotoxicity. A large fraction of these agents fall into the chemical class commonly referred to as "organic cations" (OCs), 2 i.e. a diverse array of primary, secondary, tertiary, or quaternary amines that have a net positive charge on the amine nitrogen at physiological pH. The proximal tubule is the primary site of renal OC secretion (3,5), and the first step in the process is OC entry from the blood into proximal cells across the peritubular (i.e. basolateral) membrane. Three homologous transporters (OCT1, OCT2, and OCT3) have been cloned and subsequently shown to be expressed in the basolateral membrane of proximal cells (1,6). In all species examined, including the human (7), the kinetic and selectivity profile of OCT3 and the comparatively low levels of mRNA and protein expression of this homolog in the kidney suggest that renal secretion is dominated by some combination of OCT1 and OCT2 activity. Perhaps the most convincing evidence of the significance of OCT1 and OCT2 in renal OC secretion is the observation that secretion of the prototypic OC, tetraethylammonium (TEA), is completely eliminated in OCT1/2 Ϫ/Ϫ mice (8).In human kidney, OCT2 appears to be the predominant OC transporter. Expression of mRNA for OCT2 far exceeds that for OCT1, and immunocytochemistry clearly shows a basolateral expression for OCT2 and little or no presence of OCT1 (9). There are, however, clear species differences in this profile, with subst...